1-8 of 8
J Friedman
Close
Sort by
Journal Articles

Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, for Treatment of Patients with Myeloid Growth Factor-Resistant Idiopathic Chronic Neutropenia (ICN)

Roger M. Lyons, MD, Sharon T. Wilks, MD, David J. Friedman, MD, PhD, Shelby A Young, RN, BSN, Gail Brown, MD
Journal: Blood
Blood (2012) 120 (21): 4394.
https://doi.org/10.1182/blood.V120.21.4394.4394
Published: 2012
Journal Articles

Validation of the HEMOCLOT ® Direct Thrombin Inhibitor Assay for Dabigatran by Comparison with a Validated LC-MS/MS Method in Plasma Samples From Patients After Major Orthopaedic Surgery

Joachim Stangier, PhD, Bengt I Eriksson, MD, Michael H Huo, MD, Richard J Friedman, MD, Ola E Dahl, MD, Martin Feuring, MD
Journal: Blood
Blood (2011) 118 (21): 2307.
https://doi.org/10.1182/blood.V118.21.2307.2307
Published: 2011
Journal Articles

Oral Dabigatran Etexilate Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty: A Pooled Analysis of Four Randomized Trials

Michael H Huo, MD, Andreas A Kurth, MD, Ola E Dahl, MD, Andreas Clemens, MD, Stefan Hantel, PhD, Martin Feuring, MD, Richard J Friedman, MD, Bengt I Eriksson, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2312.
https://doi.org/10.1182/blood.V118.21.2312.2312
Published: 2011
Journal Articles

Deep Vein Thrombosis and Pulmonary Embolism: Awareness and Knowledge Gaps In the General Public and at-Risk Oncology Patients

Frederick R Rickles, MD, FACP, Gregory A Maynard, MD, Richard J Friedman, MD, FRCSC, Alan P Brownstein, MPH, Elizabeth A Varga, MS, CGC, Lisa L Fullam, Jack E Ansell, MD
Journal: Blood
Blood (2010) 116 (21): 4740.
https://doi.org/10.1182/blood.V116.21.4740.4740
Published: 2010
Journal Articles

Deep Vein Thrombosis and Pulmonary Embolism: Awareness and Knowledge Gaps In the General Public

Jack E Ansell, MD, Gregory A Maynard, MD, Richard J Friedman, MD, FRCSC, Elizabeth A Varga, MS, CGC, Lisa L Fullam, Alan P Brownstein, MPH
Journal: Blood
Blood (2010) 116 (21): 4731.
https://doi.org/10.1182/blood.V116.21.4731.4731
Published: 2010
Journal Articles

Quantitative Benefit–Risk Assessment of Rivaroxaban for the Prevention of Venous Thromboembolism.

Bennett Levitan, MD, PhD, Zhong Yuan, MD, PhD, Alexander GG Turpie, MD, Richard J Friedman, MD, Martin Homering, MSPH, Jesse A Berlin, ScD, Scott D Berkowitz, MD, FACP, Peter M DiBattiste, MD, FACC
Journal: Blood
Blood (2009) 114 (22): 169.
https://doi.org/10.1182/blood.V114.22.169.169
Published: 2009
Journal Articles

Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis after Total Hip Arthroplasty: The RECORD1 Trial.

Bengt I. Eriksson, MD, PhD, Lars C. Borris, MD, Richard J. Friedman, MD, Sylvia Haas, MD, Menno V. Huisman, MD, PhD, Ajay K. Kakkar, MD, PhD, Tiemo J. Bandel, MD, Eva Muehlhofer, MD, Frank Misselwitz, MD, William Geerts, MD
Journal: Blood
Blood (2007) 110 (11): 6.
https://doi.org/10.1182/blood.V110.11.6.6
Published: 2007
Journal Articles

Mouse hematopoietic stem cells

GJ Spangrude, L Smith, N Uchida, K Ikuta, S Heimfeld, J Friedman, IL Weissman
Journal: Blood
Blood (1991) 78 (6): 1395–1402.
https://doi.org/10.1182/blood.V78.6.1395.1395
Published: 1991